Cytokine‐inducible SH2 domain containing protein contributes to regulation of adiposity, food intake, and glucose metabolism

The cytokine‐inducible SH2 domain containing protein (CISH) is the founding member of the suppressor of cytokine signaling (SOCS) family of negative feedback regulators and has been shown to be a physiological regulator of signaling in immune cells. This study sought to investigate novel functions for CISH outside of the immune system. Mice deficient in CISH were generated and analyzed using a range of metabolic and other parameters, including in response to a high fat diet and leptin administration. CISH knockout mice possessed decreased body fat and showed resistance to diet‐induced obesity. This was associated with reduced food intake, but unaltered energy expenditure and microbiota composition. CISH ablation resulted in reduced basal expression of the orexigenic Agrp gene in the arcuate nucleus (ARC) region of the brain. Cish was basally expressed in the ARC, with evidence of co‐expression with the leptin receptor (Lepr) gene in Agrp‐positive neurons. CISH‐deficient mice also showed enhanced leptin responsiveness, although Cish expression was not itself modulated by leptin. CISH‐deficient mice additionally exhibited improved insulin sensitivity on a high‐fat diet, but not glucose tolerance despite reduced body weight. These data identify CISH as an important regulator of homeostasis through impacts on appetite control, mediated at least in part by negative regulation of the anorexigenic effects of leptin, and impacts on glucose metabolism.

[1]  Tiantian Wang,et al.  Searching for the link between inflammaging and sarcopenia , 2022, Ageing Research Reviews.

[2]  Clifford Liongue,et al.  SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer , 2021, Frontiers in Medicine.

[3]  Laura F. Dagley,et al.  NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS , 2020, The Journal of experimental medicine.

[4]  M. Teixeira,et al.  SOCS2 modulates adipose tissue inflammation and expansion in mice. , 2019, The Journal of nutritional biochemistry.

[5]  S. Nicholson,et al.  SOCS-mediated immunomodulation of natural killer cells. , 2019, Cytokine.

[6]  K. Ganbarov,et al.  Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. , 2019, Microbial pathogenesis.

[7]  A. A. da Silva,et al.  Role of SOCS3 in POMC neurons in metabolic and cardiovascular regulation. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  J. Estrada,et al.  Leptin Signaling in the Control of Metabolism and Appetite: Lessons from Animal Models , 2018, Journal of Molecular Neuroscience.

[9]  M. Myers,et al.  Novel leptin receptor signaling mutants identify location and sex‐dependent modulation of bone density, adiposity, and growth , 2018, Journal of cellular biochemistry.

[10]  J. Tavernier,et al.  The intracellular domain of the leptin receptor prevents mitochondrial depolarization and mitophagy. , 2018, Biochimica et biophysica acta. Molecular cell research.

[11]  A. Yoshimura,et al.  Negative Regulation of Cytokine Signaling in Immunity. , 2018, Cold Spring Harbor perspectives in biology.

[12]  M. Roden,et al.  CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility , 2018, Molecular and Cellular Pediatrics.

[13]  E. Demerath,et al.  An epigenome-wide study of obesity in African American youth and young adults: novel findings, replication in neutrophils, and relationship with gene expression , 2018, Clinical Epigenetics.

[14]  M. Febbraio,et al.  Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice , 2017, Diabetes, obesity & metabolism.

[15]  V. Streltsov,et al.  Lysine post‐translational modification of glyceraldehyde‐3‐phosphate dehydrogenase regulates hepatic and systemic metabolism , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Evan Z. Macosko,et al.  A Molecular Census of Arcuate Hypothalamus and Median Eminence Cell Types , 2017, Nature Neuroscience.

[17]  M. Febbraio,et al.  Disruption of the Class IIa HDAC Corepressor Complex Increases Energy Expenditure and Lipid Oxidation. , 2016, Cell reports.

[18]  Laura F. Dagley,et al.  CIS is a potent checkpoint in NK cell–mediated tumor immunity , 2016, Nature Immunology.

[19]  M. Low,et al.  Sex difference in physical activity, energy expenditure and obesity driven by a subpopulation of hypothalamic POMC neurons , 2016, Molecular metabolism.

[20]  F. Marincola,et al.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance , 2015, Journal for ImmunoTherapy of Cancer.

[21]  T. Kay,et al.  Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity. , 2014, The Biochemical journal.

[22]  J. B. Kim,et al.  Crosstalk between Adipocytes and Immune Cells in Adipose Tissue Inflammation and Metabolic Dysregulation in Obesity , 2014, Molecules and cells.

[23]  M. Low,et al.  Temporal changes in nutritional state affect hypothalamic POMC peptide levels independently of leptin in adult male mice. , 2014, American journal of physiology. Endocrinology and metabolism.

[24]  Jiajie Zhang,et al.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR , 2013, Bioinform..

[25]  M. Cowley,et al.  Leptin Stimulates Neuropeptide Y and Cocaine Amphetamine-Regulated Transcript Coexpressing Neuronal Activity in the Dorsomedial Hypothalamus in Diet-Induced Obese Mice , 2013, The Journal of Neuroscience.

[26]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[27]  K. Kaestner,et al.  CISH has no non-redundant functions in glucose homeostasis or beta cell proliferation during pregnancy in mice , 2013, Diabetologia.

[28]  D. Corry,et al.  The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation , 2013, Nature Immunology.

[29]  A. Ward,et al.  SOCS proteins in development and disease. , 2013, American journal of clinical and experimental immunology.

[30]  Ian A. Trounce,et al.  Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity , 2012, Diabetes.

[31]  T. Horvath,et al.  Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis , 2012, EMBO reports.

[32]  J. Speakman Measuring Energy Metabolism in the Mouse – Theoretical, Practical, and Analytical Considerations , 2012, Front. Physiol..

[33]  G. Norstedt,et al.  SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high‐fat‐diet‐fed mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  T. Kieffer,et al.  The role of leptin in glucose homeostasis , 2012, Journal of diabetes investigation.

[35]  G. Feng,et al.  Shp2 Controls Female Body Weight and Energy Balance by Integrating Leptin and Estrogen Signals , 2012, Molecular and Cellular Biology.

[36]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[37]  T. Kay,et al.  Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance , 2011, Diabetes.

[38]  H. Münzberg,et al.  Early-life exposure to testosterone programs the hypothalamic melanocortin system. , 2011, Endocrinology.

[39]  R. Knight,et al.  UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.

[40]  Sofianos Andrikopoulos,et al.  Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1 , 2010, Hepatology.

[41]  R. Mooney,et al.  Suppressor of Cytokine Signaling-3 Is a Glucagon-inducible Inhibitor of PKA Activity and Gluconeogenic Gene Expression in Hepatocytes* , 2010, The Journal of Biological Chemistry.

[42]  M. Nawijn,et al.  Pim3 negatively regulates glucose-stimulated insulin secretion , 2010, Islets.

[43]  B. Göke,et al.  No non-redundant function of suppressor of cytokine signaling 2 in insulin producing β-cells , 2010, Islets.

[44]  J. Ruberte,et al.  The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion , 2010, Diabetologia.

[45]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[46]  W. Becker,et al.  Mechanism of attenuation of leptin signaling under chronic ligand stimulation , 2010, BMC Biochemistry.

[47]  G. Morahan,et al.  Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes , 2007, Diabetologia.

[48]  A. Yoshimura,et al.  The dual function of hepatic SOCS3 in insulin resistance in vivo , 2007, Genes to cells : devoted to molecular & cellular mechanisms.

[49]  J. Flier,et al.  Attenuation of leptin and insulin signaling by SOCS proteins , 2006, Trends in Endocrinology & Metabolism.

[50]  J. Tavernier,et al.  A complex interaction pattern of CIS and SOCS2 with the leptin receptor , 2006, Journal of Cell Science.

[51]  Eoin L. Brodie,et al.  Greengenes: Chimera-checked 16S rRNA gene database and workbench compatible in ARB , 2006 .

[52]  R. Seeley,et al.  GM-CSF action in the CNS decreases food intake and body weight. , 2005, The Journal of clinical investigation.

[53]  B. Kemp,et al.  Socs1 Deficiency Enhances Hepatic Insulin Signaling* , 2005, Journal of Biological Chemistry.

[54]  Alexander S. Banks,et al.  Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. , 2005, The Journal of clinical investigation.

[55]  W. Alexander,et al.  Development of hydrocephalus in mice lacking SOCS7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Kioussis,et al.  Insulin Induces SOCS-6 Expression and Its Binding to the p85 Monomer of Phosphoinositide 3-Kinase, Resulting in Improvement in Glucose Metabolism* , 2004, Journal of Biological Chemistry.

[57]  A. Yoshimura,et al.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity , 2004, Nature Medicine.

[58]  S. Minami,et al.  Human growth hormone induces SOCS3 and CIS mRNA increase in the hypothalamic neurons of hypophysectomized rats. , 2004, Endocrine journal.

[59]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[60]  W. Alexander,et al.  SOCS-6 Binds to Insulin Receptor Substrate 4, and Mice Lacking the SOCS-6 Gene Exhibit Mild Growth Retardation , 2002, Molecular and Cellular Biology.

[61]  S. Cameron,et al.  Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor , 2001, The Journal of Biological Chemistry.

[62]  H Remschmidt,et al.  Association between an agouti-related protein gene polymorphism and anorexia nervosa , 2001, Molecular Psychiatry.

[63]  S. Akira,et al.  Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation , 2001, The Journal of experimental medicine.

[64]  J. Flier,et al.  SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985 * , 2000, The Journal of Biological Chemistry.

[65]  J. Tavernier,et al.  Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor , 2000, FEBS letters.

[66]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[67]  E. Van Obberghen,et al.  SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.

[68]  M. Hammar,et al.  Sex differences in neuropeptide distribution in the rat brain , 1999, Peptides.

[69]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[70]  N. Copeland,et al.  A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.

[71]  A. Dunn,et al.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Krakoff,et al.  Energy expenditure in the etiology of human obesity: spendthrift and thrifty metabolic phenotypes and energy-sensing mechanisms , 2017, Journal of Endocrinological Investigation.

[73]  A. Dalpke,et al.  Suppressor of cytokine signaling proteins as regulators of innate immune signaling. , 2012, Frontiers in bioscience.

[74]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[75]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[76]  J. Levine,et al.  Neuropeptide Y gene expression in the arcuate nucleus: sexual dimorphism and modulation by testosterone. , 1993, Endocrinology.